Resources for students such as educational tools covering a variety of managed care topics and information on professional opportunities (internships, APPEs, fellowships and residencies) related to managed care pharmacy.
AMCP and AMCP Foundation are pleased to announce the recipients of the 2026 AMCP Awards, which honor individuals who have made significant contributions to the managed care profession and the AMCP organization. These awards are presented annually during the AMCP Annual Meeting.
In this video, Jessica of Chadds Ford, Pennsylvania, shares her journey living with eosinophilic esophagitis (EOE), a chronic inflammatory condition that causes difficulty swallowing and food impactions. After years of symptoms that were initially treated as acid reflux, a biopsy finally confirmed her diagnosis.
AMCP applauds the House reintroduction of the Medicaid VBPs for Patients (MVP) Act (H.R. 7871) by Rep. Brett Guthrie (KY-02) alongside Rep. Jake Auchincloss (MA-04), Rep. Mariannette Miller-Meeks (IA-01), Rep. John Joyce (PA-13), Rep. Scott Peters (CA-50), and Rep. Don Davis (NC-01). This bipartisan legislation complements Senate bill S. 1637 and aims to improve patient access to novel therapies by enhancing the use of value-based purchasing arrangements in Medicaid.
At the start of each year, AMCP brings together its Board, Foundation Officers, Committee & Affiliate leaders, and corporate partners for the Winter Leadership Meeting. It’s where we align on priorities, strengthen relationships, and ensure the work ahead reflects AMCP’s mission and trends and topics in managed care pharmacy.
As pharmacy benefit management grows more complex, managed care organizations are increasingly relying on advanced analytical tools and RWE to guide coverage decisions, streamline utilization management, and support value-based reimbursement strategies. With specialty therapies commanding rising spend and policy shifts affecting patient access and affordability, the integration of AI and RWE is gaining traction among payers and their partners as a strategic imperative.
On March 3, 2026, the Centers for Medicare & Medicaid Services (CMS) issued Frequently Asked Questions (FAQs) about the Medicare GLP-1 Bridge (the Bridge).
The Bridge will offer early access to GLP-1 drugs for weight loss to eligible Medicare Part D beneficiaries.
In February 2026, Senators Elizabeth Warren (D-MA) and Josh Hawley (R-MO) introduced the Break Up Big Medicine Act (S. 3822). The bipartisan legislation, referred to the Senate Judiciary Committee, aims to prohibit pharmacy benefit managers (PBMs), health insurers, and prescription drug or medical device wholesalers from being under common ownership with certain medical service providers or provider groups, including in-patient or outpatient pharmacies.
